3-hydroxyflavone has been researched along with Cholangiocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, MJ; Kim, BH; Kim, N; Kim, YT; Lee, JM; Lee, JS; Lee, SH; Ryu, JK; Son, JH | 1 |
1 other study(ies) available for 3-hydroxyflavone and Cholangiocarcinoma
| Article | Year |
|---|---|
Fisetin Reduces Cell Viability Through Up-Regulation of Phosphorylation of ERK1/2 in Cholangiocarcinoma Cells.
Topics: Cell Line, Tumor; Cell Survival; Cholangiocarcinoma; Deoxycytidine; Flavonoids; Flavonols; Gemcitabine; Humans; MAP Kinase Signaling System; Phosphorylation; Up-Regulation | 2016 |